Title: 2025-2026 Regular Session HR 287 PN 2410 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN2410
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 287 PN 2410 Bill Text (HTM) See other bills under thesame topic PRIOR PRINTER'S NO. 2156PRINTER'S NO. 2410THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.287 Session of 2025 INTRODUCED BY SHUSTERMAN, HILL-EVANS, PIELLI, OTTEN, SANCHEZ, HANBIDGE, GUENST, HOHENSTEIN, D. WILLIAMS, CURRY AND GREEN, JULY 18, 2025 AS REPORTED FROM COMMITTEE ON HEALTH, HOUSE OF REPRESENTATIVES, AS AMENDED, OCTOBER 7, 2025A RESOLUTIONDirecting the Joint State Government Commission to conduct a study and issue a report on workplace policies related to perimenopause and menopause offered by public and private employers.WHEREAS, Menopause is defined as the point at which a woman has not menstruated for a continuous period of 12 months, with the transitional period leading to menopause commonly referred to as perimenopause; andWHEREAS, Perimenopause and menopause are frequently associated with symptoms that may include weight gain, joint and muscle pain, cognitive impairment often described as brain fog, increased risk of depression and anxiety, hot flashes, night sweats, sleep disturbances, changes in sexual function, bone loss, fluctuations in cholesterol levels and vaginal and urinary tract complications; andWHEREAS, In ACCORDING TO THE NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, IN the United States, approximately 1.3 million women enter menopause annually, with the average age <--123456789101112131415161718 of onset at 51 years of age; andWHEREAS, The ACCORDING TO A MAYO CLINIC STUDY, THE symptoms associated with perimenopause and menopause may result in absenteeism, reduced workplace productivity and increased health care costs, with economic estimates indicating that lost productivity and medical expenses related to these symptoms total approximately $26.6 billion per year nationwide; andWHEREAS, Treatment options for perimenopausal and menopausal symptoms may include hormone replacement therapy, prescription medications and dietary or lifestyle modifications, yet many women remain unaware of the available interventions; andWHEREAS, A study conducted by the American Association of Retired Persons found that only approximately 61% of women in the perimenopausal stage felt knowledgeable about menopause; andWHEREAS, The same study indicated that more than half of the women surveyed believed there should be greater focus on menopause education and women's health generally; andWHEREAS, The House of Representatives is committed to advancing the health and well-being of women in this Commonwealth and ensuring that accurate, accessible information concerning perimenopause and menopause is widely disseminated and promoted; therefore be itRESOLVED, That the House of Representatives direct the Joint State Government Commission to conduct a study and issue a report on workplace policies related to perimenopause and menopause offered by public and private employers; REGARDING INFORMATION READILY AVAILABLE RELATED TO PERIMENOPAUSE AND MENOPAUSE; and be it furtherRESOLVED, That the study include the following components:(1) An examination of existing perimenopause-related and 20250HR0287PN2410 - 2 - <--<--<--<--123456789101112131415161718192021222324252627282930 menopause-related education and awareness policies in both public and private sector workplaces.(2) A review of workplace policies related to perimenopause and menopause, including policies concerning reasonable accommodations, paid leave and other supports for employees experiencing perimenopause-related and menopause-related symptoms.(1) CONSULTATION WITH EXPERTS IN PERIMENOPAUSE AND MENOPAUSE FROM VARIOUS FIELDS, INCLUDING MEDICINE AND LAW.(2) A REVIEW OF WORKPLACE POLICIES FOR COMMONWEALTH EMPLOYEES RELATED TO SUPPORTS FOR COMMONWEALTH EMPLOYEES EXPERIENCING PERIMENOPAUSE-RELATED AND MENOPAUSE-RELATED SYMPTOMS.(3) Recommendations for actions AND EDUCATIONAL MATERIALS that the Department of Human Services, the Department of Health, THE DEPARTMENT OF LABOR AND INDUSTRY or other appropriate State agencies may implement OR POST ON THEIR PUBLICLY ACCESSIBLE INTERNET WEBSITES to support women during the perimenopausal and menopausal life stages.(4) A REVIEW OF LAWS, POLICIES AND EDUCATIONAL MATERIALS PROVIDED BY OTHER STATES.(4) (5) Legislative recommendations that the House of Representatives may consider to improve public understanding of and support for women experiencing perimenopause and menopause;and be it furtherRESOLVED, That the Joint State Government Commission report its findings and recommendations to the House of Representatives no later than 18 months following the adoption of this resolution.20250HR0287PN2410 - 3 - <--<--<--<--<--<--123456789101112131415161718192021222324252627282930


================================================================================

Raw Text:
2025-2026 Regular Session HR 287 PN 2410 Bill Text (HTM) See other bills under thesame topic PRIOR PRINTER'S NO. 2156PRINTER'S NO. 2410THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.287 Session of 2025 INTRODUCED BY SHUSTERMAN, HILL-EVANS, PIELLI, OTTEN, SANCHEZ, HANBIDGE, GUENST, HOHENSTEIN, D. WILLIAMS, CURRY AND GREEN, JULY 18, 2025 AS REPORTED FROM COMMITTEE ON HEALTH, HOUSE OF REPRESENTATIVES, AS AMENDED, OCTOBER 7, 2025A RESOLUTIONDirecting the Joint State Government Commission to conduct a study and issue a report on workplace policies related to perimenopause and menopause offered by public and private employers.WHEREAS, Menopause is defined as the point at which a woman has not menstruated for a continuous period of 12 months, with the transitional period leading to menopause commonly referred to as perimenopause; andWHEREAS, Perimenopause and menopause are frequently associated with symptoms that may include weight gain, joint and muscle pain, cognitive impairment often described as brain fog, increased risk of depression and anxiety, hot flashes, night sweats, sleep disturbances, changes in sexual function, bone loss, fluctuations in cholesterol levels and vaginal and urinary tract complications; andWHEREAS, In ACCORDING TO THE NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, IN the United States, approximately 1.3 million women enter menopause annually, with the average age <--123456789101112131415161718 of onset at 51 years of age; andWHEREAS, The ACCORDING TO A MAYO CLINIC STUDY, THE symptoms associated with perimenopause and menopause may result in absenteeism, reduced workplace productivity and increased health care costs, with economic estimates indicating that lost productivity and medical expenses related to these symptoms total approximately $26.6 billion per year nationwide; andWHEREAS, Treatment options for perimenopausal and menopausal symptoms may include hormone replacement therapy, prescription medications and dietary or lifestyle modifications, yet many women remain unaware of the available interventions; andWHEREAS, A study conducted by the American Association of Retired Persons found that only approximately 61% of women in the perimenopausal stage felt knowledgeable about menopause; andWHEREAS, The same study indicated that more than half of the women surveyed believed there should be greater focus on menopause education and women's health generally; andWHEREAS, The House of Representatives is committed to advancing the health and well-being of women in this Commonwealth and ensuring that accurate, accessible information concerning perimenopause and menopause is widely disseminated and promoted; therefore be itRESOLVED, That the House of Representatives direct the Joint State Government Commission to conduct a study and issue a report on workplace policies related to perimenopause and menopause offered by public and private employers; REGARDING INFORMATION READILY AVAILABLE RELATED TO PERIMENOPAUSE AND MENOPAUSE; and be it furtherRESOLVED, That the study include the following components:(1) An examination of existing perimenopause-related and 20250HR0287PN2410 - 2 - <--<--<--<--123456789101112131415161718192021222324252627282930 menopause-related education and awareness policies in both public and private sector workplaces.(2) A review of workplace policies related to perimenopause and menopause, including policies concerning reasonable accommodations, paid leave and other supports for employees experiencing perimenopause-related and menopause-related symptoms.(1) CONSULTATION WITH EXPERTS IN PERIMENOPAUSE AND MENOPAUSE FROM VARIOUS FIELDS, INCLUDING MEDICINE AND LAW.(2) A REVIEW OF WORKPLACE POLICIES FOR COMMONWEALTH EMPLOYEES RELATED TO SUPPORTS FOR COMMONWEALTH EMPLOYEES EXPERIENCING PERIMENOPAUSE-RELATED AND MENOPAUSE-RELATED SYMPTOMS.(3) Recommendations for actions AND EDUCATIONAL MATERIALS that the Department of Human Services, the Department of Health, THE DEPARTMENT OF LABOR AND INDUSTRY or other appropriate State agencies may implement OR POST ON THEIR PUBLICLY ACCESSIBLE INTERNET WEBSITES to support women during the perimenopausal and menopausal life stages.(4) A REVIEW OF LAWS, POLICIES AND EDUCATIONAL MATERIALS PROVIDED BY OTHER STATES.(4) (5) Legislative recommendations that the House of Representatives may consider to improve public understanding of and support for women experiencing perimenopause and menopause;and be it furtherRESOLVED, That the Joint State Government Commission report its findings and recommendations to the House of Representatives no later than 18 months following the adoption of this resolution.20250HR0287PN2410 - 3 - <--<--<--<--<--<--123456789101112131415161718192021222324252627282930